詳細検索結果
以下の条件での結果を表示する: 検索条件を変更
クエリ検索: "ヒトクローニング"
8件中 1-8の結果を表示しています
  • 秋葉 悦子
    生命倫理
    2003年 13 巻 1 号 12-19
    発行日: 2003/09/18
    公開日: 2017/04/27
    ジャーナル フリー
    国際的な生命倫理の基本原則としての「人間の尊厳」と、ヒトの始まりについての生物学的事実は、必然的にヒト胚の科学実験を禁ずる。
  • 高久 史麿
    生命倫理
    1999年 9 巻 1 号 188-189
    発行日: 1999/09/13
    公開日: 2017/04/27
    ジャーナル フリー
  • 森岡 正博
    生命倫理
    2008年 18 巻 1 号 83-89
    発行日: 2008/09/21
    公開日: 2017/04/27
    ジャーナル フリー
    この論文で私は、人文系の研究者たちが現代的な生命の問題を議論するための「生命人文学」という新しい研究領域の必要性を提唱する。日本の学術的な生命倫理学は、医学領域に「医療倫理学」の専門分野を確立したが、それに対して、現代的な生命の問題への包括的な人文学のアプローチはいまだ成立していない。私が提唱する「生命人文学」は、次のような問い、たとえば「生命科学の発展によって人間は幸福になれるのか」「科学技術が発展する中で人間はいかにして尊厳を保つことができるのか」「人間が自然環境と調和的な関係を取り結ぶことは可能なのか」「すべての人が充実した生と死を全うすることのできる社会とはどのような社会か」などを議論する。米国やヨーロッパにおいては、この種の研究はどうしてもキリスト教からの大きな影響下に置かれることになるが、宗教教団が生命倫理の問題に対して大きな力を持たない日本においては、宗教的な影響をさほど受けずにこれらの問題を人文学的に議論することができる可能性がある。この研究プロジェクトはインターネットを介して情報や意見をリアルタイムで交換し共有するという高度なスキルを要求するものであるから、情報学と密接に連携した研究開発が必要となるであろう。
  • 日本学術会議50周年記念日本学術会議主催公開講演会
    学術の動向
    1999年 4 巻 5 号 68-73
    発行日: 1999/05/01
    公開日: 2009/12/21
    ジャーナル フリー
  • 福田 康恵
    日本EU学会年報
    2008年 2008 巻 28 号 221-241,327
    発行日: 2008/04/01
    公開日: 2011/04/13
    ジャーナル フリー
    The globalization of medical research and the application of biotechnology are presenting us with a wide range of economic and ethical issues. This paper will examine the controversies surrounding biomedical research policy and bio-ethics in the EU and its Member States with particular emphasis on the ethical raised by human embryonic stem-cell research from the viewpoint of “bio-politics”. It is essential to ensure that moral value as well as economic merits are reflected in public policy making.
    This paper focuses on bio-medical research, and analyzes many ethical issues involving human embryonic stem cell. And policy issues from a viewpoint of bio-politics technology by embryonic stem cell research an example also in the EU science and technology policies.
    It is necessary to also make moral value reflect in a public policy simultaneously with economic merit. Society does desire of the progress of medical and technology, and although it is common profits for civil society, various ethical problems exist in adaptation of the technology. Moreover, medical and technological research and the medical service itself are realized to be industries, and the economic earnings are pursued in many cases. However, since commercializing and dealing in human internal organs and ovum is greatly concerned also with the dignity of the economic discrepancy in domestic and international society, and a human being, international regulation of the suitable control to these tip life medical and technological development research policy and the EU level is demanded. Medical research must be evaluated not only from the financial side but from an ethics side about influence on the society. In order to perform a medical technical policy on the EU level, it is necessary to obtain an understanding of the European citizen's policy, and the transparency of a policy and reservation of accountability are indispensable. It is very useful to aim at adjustment of the sense of ethics in the EU level and policy harmonization in the Member States by Open Method of Co-ordination.
    The framework of carrying out control by social regulations to an advanced medical and technical policy by performing an ethical fixed value judgement can be said that the meaning which EU showed is very large.
  • 21世紀の遺伝学の発展をめぐる法•政策•生命倫理の新たな課題
    和田 幹彦
    法社会学
    2005年 2005 巻 62 号 41-53,191
    発行日: 2005/03/30
    公開日: 2011/04/13
    ジャーナル フリー
    Genetic sciences, especially in the area of molecular biology, pose serious challenges and problems to us in the 21st Century. Genetic information of individuals gives new hopes and worries to patients and their families in their medical decision-makings. New technologies may also make human germline engineering possible and safe in the near future.
    The first half of the paper discusses the autonomy of patients and of their families in medical decision-makings, while we face awesome developments in genetics and genetic information. If a simple informed consent represented the autonomy in the last decades of the 20th Century, should our autonomy in the 21st Century include our right (or duty) of letting our family and relatives know of their potential genetic information and genetic (advantages or) risks? Should it also include our and their right to "remain in blessed ignorance"? The novelty facing us in this century is that newly accessible genetic information of individuals (1) does not change, in that his DNA sequences stay the same life-long, (2) does not necessarily indicate the current physical condition, but could predict probabilities of certain diseases, (3) may lead to such prediction that may bring about discrimination, and finally, (4) may lead to presumptions on genetic information and conditions of families and relatives. The individual autonomy in this century, therefore, may afflict and conflict with the autonomy of others, even more than it did in the last century. The paper cites and discusses in details a lawsuit decided on April 25, 2003 in Tokyo District Court, then later on January 27, 2005 in Tokyo High Court, where the plaintiffs (parents) were awarded generous compensation for not being informed by physician (s) of genetic risks of having new babies, even after their first born had a severe genetic disease. The paper proposes that professional genetic counseling would be a key solution to such newly arising (legal) problems of this century.
    The second half of this paper discusses reproductive human cloning and germline engineering, i.e. "Designer Children." Japan, in step with several other countries, prohibited reproductive cloning by law. There still are, however, limitations to the current regulation of genetic technologies in the international community. This paper discusses the recent "trial and error" by an Ad Hoc Committee and Sixth Committee of the United Nations General Assembly on an International Convention Against the Reproductive Cloning of Human Beings. They failed to agree on this treaty to ban reproductive human cloning despite the prevalent consensus that cloning babies should be prevented. The paper discusses then how the miscarriage of the International Convention might have closed the path to a future multilateral agreement to regulate or prohibit germline engineering. The discussions cover the "charm" as well as the risk, and the pros and cons of designing children. The paper contends that any potential regulation of germline engineering must consist of pragmatic measures that are viable within existing legal and social structures.
    Finally, the paper discusses how law and regulation, including timely provision of appropriate genetic counselors and counseling, might fail to keep up with the rapid development of science and technology. A common criticism voiced in Japan is that law, legal regulation, and social controls cannot level with the fast development of science and technology. The solution would be proposing and stockpiling possible and pragmatic measures well in advance, before another Dolly II the Designer Sheep would alarm us. Also, we probably should not expect a one and only truthful answer to all the bioethical questions on novel biotechnology and life sciences. Diversity, be it on the national or the international level, requires and should tolerate diverse responses to those questions.
  • 金 承哲
    宗教研究
    2009年 83 巻 2 号 431-451
    発行日: 2009/09/30
    公開日: 2017/07/14
    ジャーナル フリー
    「クローン羊ドリー」をめぐる論争が示すように、遺伝子工学を含む昨今の生命科学は、人間の自己についての理解に新たな問いを投げかけ、それによって、自己と他者の間の境界を始め、人間と自然の間の境界、さらには、人間と神の間の境界についての既存の観念は大きく揺らいでいる。特に、神による「創造の秩序」を実在理解の基本とするキリスト教世界においては、生命科学が提起する問題は極めて深刻に受けとめられている。倫理とはこうした「境界」をめぐる議論であるということを考えてみると、生命工学的試みが倫理的問いを伴うことは当然であろう。キリスト教においては、こうした倫理的問題が「神を演じる」(Paying God)という観念の下で議論される。本稿は、生命科学と倫理の関係性と、生命科学によってもたらされた新たな自己理解について論じることによって、生命科学によってもたらされる自己理解の倫理的意味について考察する。
  • Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz
    医療と社会
    2003年 13 巻 2 号 2_41-2_84
    発行日: 2003年
    公開日: 2010/02/02
    ジャーナル フリー
feedback
Top